In the News: Goldman Sachs-CSRC Settlement; First Sci-Tech Board Funds Approved; and Drug Administration Law Under Review
Apr 29, 2019
| By Marilyn Romero
The CSRC has agreed its first administrative settlement with Goldman Sachs and Gao Hua Securities; seven themed funds were approved for Shanghai’s new Sci-Tech Board; and the National People's Congress is reviewing measures to tighten up the production and sale of drugs.
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
This premium content is reserved for China Law & Practice Subscribers.
A Premium Subscription Provides:
A database of over 3,000 essential documents including key PRC legislation translated into English
A choice of newsletters to alert you to changes affecting your business including sector specific updates
Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment